Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nektar Therapeutics

    NASDAQ: NKTR · Real-Time Price · USD
    26.48
    -0.95 (-3.46%)
    At close: Aug 19, 2025, 12:09 PM

    Nektar Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 98.43M 90.12M 92.06M 101.91M
    Cost of Revenue
    		 30.69M 36.64M 21.64M 24.9M
    Gross Profit
    		 67.74M 53.48M 70.42M 77.01M
    Operating Income
    		 -105.2M -137.43M -240.24M -446.1M
    Interest Income
    		 14.5M 19.01M 6.78M 2.57M
    Pretax Income
    		 -119.2M -276.26M -364.98M -523.28M
    Net Income
    		 -118.96M -276.06M -368.2M -523.84M
    Selling & General & Admin
    		 76.75M 77.42M 92.33M 122.84M
    Research & Development
    		 120.91M 114.16M 218.32M 400.27M
    Other Expenses
    		 -24.72M -676K n/a n/a
    Operating Expenses
    		 172.94M 190.9M 310.66M 523.11M
    Interest Expense
    		 28.11M 25.33M 28.91M 47.31M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 203.63M 227.55M 332.29M 548.01M
    Income Tax Expense
    		 -239K -200K 3.21M 557K
    Shares Outstanding (Basic)
    		 13.71M 12.67M 12.48M 12.22M
    Shares Outstanding (Diluted)
    		 13.71M 12.67M 12.48M 12.22M
    EPS (Basic)
    		 -8.68 -21.79 -29.51 -42.87
    EPS (Diluted)
    		 -8.68 -21.79 -29.51 -42.87
    EBITDA
    		 -86.7M -243.11M -323.87M -462.97M
    EBIT
    		 -91.09M -250.92M -336.07M -475.97M
    Depreciation & Amortization
    		 4.39M 7.82M 12.2M 13M

    Add to Watchlist